AUTHOREA
Log in Sign Up Browse Preprints
LOG IN SIGN UP
Madalyn Walsh
Madalyn Walsh

Public Documents 3
Anaphylaxis Following Chlorhexidine Use in the Setting of Peripheral Access Insertion...
Madalyn Walsh
Carolyn Kay-Buckelew

Madalyn Walsh

and 3 more

August 25, 2024
Chlorhexidine gluconate (CHG) is a topical antiseptic and surgical scrub increasingly implicated in periprocedural anaphylaxis. We present four patients who had anaphylaxis in the setting of CHG exposure, an agent that has been increasingly implicated in periprocedural anaphylaxis. Catheters can be impregnated with CHG and overlooked as a source of exposure resulting in anaphylaxis.
Tongue Necrosis as a Manifestation of Immune Dysfunction: A Complex Case of Lupus, Hi...
Madalyn Walsh
Alcik Feng

Madalyn Walsh

and 3 more

March 28, 2023
Tongue Necrosis as a Manifestation of Immune Dysfunction: A Complex Case of Lupus, Histoplasmosis, and Macrophage Activation SyndromeMadalyn Walsh, MD1, Alick Feng, MD2, Petar Lenart, MD PhD2, Bharat Kumar, MD MME21Department of Internal Medicine, University of Iowa Hospitals & Clinics2Division of Immunology, University of Iowa Hospitals & Clinics
Disseminated Fungal Infection in a Patient Receiving Zanubrutinib
Madalyn Walsh
Alice Xu

Madalyn Walsh

and 3 more

March 28, 2023
Introduction Zanubrutinib is a second generation Bruton’s tyrosine kinase inhibitor (BTKi) often used to treat B cell malignancies such as marginal zone lymphoma. BTKis belong to a protein tyrosine kinase family that plays an essential role in the proliferation, differentiation, and survival of B cells. The side effects of BTKis include infection, diarrhea, skin rash, and atrial fibrillation. Invasive fungal infections have been previously described with Ibrutinib (a first generation BTKi) but seldom with second generation BTKis such as zanubrutinib.

| Powered by Authorea.com

  • Home